Page 23 - Astrazeneca

AstraZeneca's Japanese Covid-19 vaccine trial back up, US still paused

Clinical trials of AstraZeneca and Oxford University's experimental Covid-19 vaccine have resumed in Japan, almost a month after being put on hold, while discussions with US authorities continue

ICMR launches a new vaccine portal for Covid, with details of trials

The portal covers other ailments as well; will provide details of progress made locally and globally at regular intervals

ICMR exploring saliva-based tests to diagnose Covid-19: Harsh Vardhan

Vardhan also said that no significant or drastic mutations had been found in strains of SARS-CoV-2 in India till now

World Coronavirus Dispatch: World economy to shrink 4.5% this yr, says OECD

The better view reflects the strong economic pickup in recent months and the vast injection of public resources

Govt in talks with Russia for advancement of Covid-19 vaccine: Health Min

The Central Drugs Standard Control Organisation (CDSCO) has informed that it has received information about one Covid-19 vaccine developed and approved in Russia

USFDA's Hahn plans significant work with AstraZeneca in Covid trial inquiry

The top US Food and Drug Administration official confirmed AstraZeneca's US Covid-19 vaccine trial is on hold

Some volunteers quit J&J Covid-19 trial in Spain after AstraZeneca scare

MADRID (Reuters) - Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.

WHO praises AstraZeneca for pausing coronavirus vaccine global trial

A WHO official on Tuesday said that the decision by AstraZeneca to pause global trials of its experimental coronavirus vaccine after an unexplained illness showed the firm was prioritising safety

AstraZeneca coronavirus vaccine trial in US on hold until midweek: Report

AstraZeneca on Saturday said it had restarted its trial in Britain after regulators completed their review of a serious side effect in one trial participant there

Not enough Covid-19 vaccines for everybody till 2024 end: Adar Poonawalla

Poonawalla estimates that the world will need 15 billion doses of the vaccine if it is taken in two steps

AstraZeneca-Oxford's coronavirus vaccine trials resume in Brazil

AstraZeneca paused global trials temporarily last week after an unexplained illness in a participant in Britain.

AstraZeneca resumes Oxford Covid vaccine trial after UK green signal

The late-stage trials of the experimental vaccine, one of the most advanced in development, were suspended this week after an illness in a study subject in Britain

DCGI aks Serum Institute to suspend recruitment for Oxford vaccine trials

DCGI has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate

Top headlines: AstraZeneca still aiming for vaccine; MGNREGS fund drying up

From India awaiting drug regulator's nod to restart the vaccine trial to drying up MGNREGA funds, here are top headlines this morning

AstraZeneca still aiming for Oxford Covid-19 vaccine by year-end, says CEO

Soriot sought to reassure investors after the company and its partner confirmed earlier this week that they had temporarily stopped giving people the experimental shot

Covid-19: Indian sites await DCGI nod to restart Oxford vaccine trial

The Drug Controller General of India (DCGI) V G Somani will take a call after he receives data from the Data and Safety Monitoring Board (DSMB) in the UK as well as India

AstraZeneca's pause on Covid-19 vaccine trial a 'wake-up call', says WHO

"This is a wake-up call to recognise that there are ups and downs in clinical development and that we have to be prepared," Soumya Swaminathan told a virtual briefing from Geneva

Covid-19: Serum Institute puts Oxford vaccine's India trials on hold

Serum Institute of India (SII) on Thursday said it is pausing clinical trials of AstraZeneca Oxford COVID-19 vaccine candidate in the country. Earlier this week, AstraZeneca said it had paused the trials because of 'an unexplained illness' in a participant in the study. However, SII on Wednesday said it was continuing with the trials and had not faced any issues. SII's latest announcement also comes against the backdrop of the central drug regulator DCGI issuing a show-cause notice to SII for not informing it about AstraZeneca pausing the clinical trials of the Oxford vaccine candidate in other countries. "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials," SII said in a statement. The Pune-based vaccine maker also said it is following instructions of the Drugs Controller General of India (DCGI), it added. In the show-cause notice, DCGI V G Somani had asked SII as to why the permission granted for conducting phase 2 and 3 clinical trial

Serum Institute puts India trials of AstraZeneca's Covid-19 vaccine on hold

Serum Institute of India has put trials of AstraZeneca's Covid-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said

India's single-day spike, Trump downplaying virus, FB's anti-vaxxer posts

On Wednesday, Maharashtra and Delhi recorded their highest single-day spike of 23,816 and 4,039 cases, respectively